Skip to main content

Fiscal Wizard · Single-issue tearsheet

ANIP / Jun 22, 2026 Run #7621

ANIP

ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Composite verdict

D 32.4 / 100
Bearish setup · Reversal 8 drivers · 2 gates blocking
  • Declining Volume
  • Engulfing
  • Stochastic Cross
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 30th of 85 in Drug Manufacturers - Specialty & Generic

rescore-sweep
Technical synthesisRegime: range
Bull 0%Evidence: High · 16 signals100% Bear
Momentum Bearish 38Mean-reversion Bearish 25

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -48%
Asset value $23.78Earnings power value $44.13Price $79.49

Priced above its no-growth earnings power value ($44.13/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Above average

57.5 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Margin of Safety 0
Revenue Growth (YoY) 100
OCF to Net Income 0
Free Cash Flow Yield 100
Cash Conversion 0

Technicals Bearish

7.2 / 100

Bearish setup leads (Declining Volume, Engulfing, Stochastic Cross); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Accumulation/Distribution Line 13
Declining Volume 14
MA Rejection 16

Risk Gates

2 blocking 5 caution

2 guards active, 23 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Altman Z-Score Caution

Bottom-band Altman Z blocks bullish signals — distress risk.

Quick Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for ANIP.